LIPOSTABIL
DEAD

Serial Number

78277602

Owner

A. NATTERMANN & CIE. GMBH

Attorney

MARGARET H BITLER

Filing Date

Jul 23, 2003

Add to watchlist:

No watchlists yet
View on USPTO

LIPOSTABIL Trademark

Serial Number: 78277602 • Registration: 2912914

LIPOSTABIL is a trademark filed by A. NATTERMANN & CIE. GMBH on July 23, 2003. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

A. NATTERMANN & CIE. GMBH (68 trademarks)

5 COLOGNE 30 , DE

Entity Type: 03

Trademark Details

Filing Date

July 23, 2003

Registration Date

December 21, 2004

Published for Opposition

September 28, 2004

Cancellation Date

July 22, 2011

Goods & Services

pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues

providing a website on global computer networks featuring information on pharmaceutical preparations in the fields of pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 22, 2011 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 17, 2005 TCCA
REGISTERED-PRINCIPAL REGISTER
Dec 21, 2004 R.PR
PUBLISHED FOR OPPOSITION
Sep 28, 2004 PUBO
NOTICE OF PUBLICATION
Sep 8, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 19, 2004 CNSA
LETTER OF SUSPENSION E-MAILED
Jul 13, 2004 GNSL
AMENDMENT FROM APPLICANT ENTERED
Jun 30, 2004 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2004 CRFA
PAPER RECEIVED
Jun 30, 2004 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2004 TROA
NON-FINAL ACTION E-MAILED
Dec 20, 2003 GNRT
ASSIGNED TO EXAMINER
Dec 15, 2003 DOCK